Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 242

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

EAACI guidelines on allergen immunotherapy: Prevention of allergy

Open access
Halken, Susanne, Larenas‐Linnemann, Desiree, Roberts, Graham, Calderón, Moises A., Angier, Elisabeth, Pfaar, Oliver, Ryan, Dermot, Agache, Ioana, Ansotegui, Ignacio J., Arasi, Stefania, Du Toit, George, Fernandez‐Rivas, Montserrat, Geerth van Wijk, Roy, Jutel, Marek, Kleine‐Tebbe, Jörg, Lau, Susanne, Matricardi, Paolo M., Pajno, Giovanni B., Papadopoulos, Nikolaos G., Penagos, Martin, Santos, Alexandra F., Sturm, Gunter J., Timmermans, Frans, van Ree, R., Varga, Eva‐Maria, Wahn, Ulrich, Kristiansen, Maria, Dhami, Sangeeta, Sheikh, Aziz, Muraro, Antonella · 2017 · Pediatric Allergy and Immunology

Abstract

Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT) is a disease‐modifying treatment for IgE‐mediated allergic disease with effects beyond cessation of AIT that may include important preventive effects. The European Academy of Allergy and Clinical Immunology (EAACI) has developed a clinical practice guideline to provide evidence‐based recommendations for AIT for the prevention of (i) development of allergic comorbidities in those with established allergic diseases, (ii) development of first allergic condition, and (iii) allergic sensitization. This guideline has been developed using the Appraisal of Guidelines for Research & Evaluation (AGREE II) framework, which involved a multidisciplinary expert working group, a systematic review of the underpinning evidence, and external peer‐review of draft recommendations. Our key recommendation is that a 3‐year course of subcutaneous or sublingual AIT can be recommended for children and adolescents with moderate‐to‐severe allergic rhinitis (AR) triggered by grass/birch pollen allergy to prevent asthma for up to 2 years post‐AIT in addition to its sustained effect on AR symptoms and medication. Some trial data even suggest a preventive effect on asthma symptoms and medication more than 2 years post‐AIT. We need more evidence concerning AIT for prevention in individuals with AR triggered by house dust mites or other allergens and for the prevention of allergic sensitization, the first allergic disease, or for the prevention of allergic comorbidities in those with other allergic conditions. Evidence for the preventive potential of AIT as disease‐modifying treatment exists but there is an urgent need for more high‐quality clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/pai.12807

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 242

Metadata

Authors
Halken, S., Larenas‐Linnemann, D., Roberts, G., Calderón, M. A., Angier, E., Pfaar, O., Ryan, D., Agache, I., Ansotegui, I. J., Arasi, S., Du Toit, G., Fernandez‐Rivas, M., Geerth van Wijk, R., Jutel, M., Kleine‐Tebbe, J., Lau, S., Matricardi, P. M., Pajno, G. B., Papadopoulos, N. G., Penagos, M., Santos, A. F., Sturm, G. J., Timmermans, F., van Ree, R., Varga, E., Wahn, U., Kristiansen, M., Dhami, S., Sheikh, A., & Muraro, A.
Venue
Pediatric Allergy and Immunology
Publisher
Wiley
Published
2017-10-27
Volume
28
Issue
8
Pages
728-745
ISSN
  • 0905-6157 (ISSN-L)
  • 1399-3038
OpenAlex
W2754886464
Cited by
242
References
6
FWCI
18.64
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.